Hip Resurfacing Technology Aids S&N Stock Gain In Q1 - Index Up 1.1%
This article was originally published in The Gray Sheet
Executive Summary
Investor enthusiasm for hip resurfacing's market potential was among factors contributing to Smith & Nephew's 21.3% stock price gain in the first quarter
You may also be interested in...
Smith & Nephew Unveils CEO Succession Plan, Cost-Cutting Measures
Incoming Smith & Nephew CEO David Illingworth's top priority will be a cost-cutting strategy to improve profit margins by an average of 1% annually through 2010
Smith & Nephew Unveils CEO Succession Plan, Cost-Cutting Measures
Incoming Smith & Nephew CEO David Illingworth's top priority will be a cost-cutting strategy to improve profit margins by an average of 1% annually through 2010
Smith & Nephew Plus: $889 Million Buy Expands European Reconstruction Biz
Smith & Nephew will double its share of the European orthopedic reconstructive implant market with its $889 million acquisition of Plus Orthopedic Holding